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Abstract
Different prostaglandins (PG) seem to have luteolytic or luteotrophic function in relation to the phases 
of life of the human corpus luteum and in-vitro studies demonstrate a luteotrophic function of PGE2, 
PGI2, PGD2. The present study evaluated the effect of an inhibitor of prostaglandin synthesis on the 
hypophyseal and luteal responses to gonadotrophin-releasing hormone (GnRH) in women during the 
mid-luteal  phase.  Twenty  normal  menstruating  women  participated  in  the  study.  Two  different 
protocols  were  applied.  After  monitored  ovulation  (day  0),  eight  patients  were  treated  with 
indomethacin for 7 days and 12 untreated patients served as controls. To evaluate luteal progesterone 
production, blood samples were taken every 15 min for 2 h basally and after a bolus of GnRH (25 
micrograms  i.v.);  eight  control  patients  were also  treated  with  indomethacin  for  one  day,  and  the 
endocrine  study was repeated.  The  long-term administration  of  indomethacin  significantly  reduced 
basal as well as luteinizing hormone (LH)-stimulated progesterone production by the corpus luteum in 
respect to controls. Short-term administration failed to influence basal progesterone production,  but 
abolished its secretory response to LH. A luteotrophic role for prostaglandins in human luteal function 
is suggested.
